Kenneth W. O'Keefe, Director at Jazz Pharmaceuticals plc (JAZZ), bought 2,000 shares at $112.45 ($228K) on 2016-11-14, disclosed to the SEC on 2016-11-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $114.30 | 1,200 | $137K | 60.2% |
| 2 | $114.33 | 300 | $34K | 15.1% |
| 3 | $112.45 | 500 | $56K | 24.7% |
| Total | $113.84 avg | 2,000 | $228K | 100% |
| Filing → |
| JAZZ | SELL | 2022-08-09 | $332K | — | Filing → |
| JAZZ | SELL | 2021-08-10 | $386K | — | Filing → |
| JAZZ | SELL | 2020-11-09 | $3.4M | — | Filing → |